Lineage Cell Therapeutics Inc (LCTX)

Jun 13, 2025

Two Sigma Investments LP Buys New Shares in Lineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX) - Defense World

Jun 13, 2025

Jun 11, 2025

Rising Demand in Allogeneic Stem Cells Market USD 2.0Bn By 2031 - openPR.com

Jun 11, 2025

Jun 11, 2025

Squarepoint Ops LLC Takes $46,000 Position in Lineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX) - Defense World

Jun 11, 2025

Jun 10, 2025

Cell Therapy Manufacturing Market Exclusive Report with Detailed Study Analysis | WuXi AppTec, Healios Ltd. - newstrail.com

Jun 10, 2025

Jun 09, 2025

Lineage Cell Therapeutics appoints new auditor - Investing.com Australia

Jun 09, 2025

Jun 09, 2025

Two Sigma Advisers LP Has $44,000 Holdings in Lineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX) - Defense World

Jun 09, 2025

Jun 08, 2025

Jane Street Group LLC Buys 142,965 Shares of Lineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX) - Defense World

Jun 08, 2025

Jun 05, 2025

Lineage Cell Therapeutics Announces Updates to the 3rd Annual Spinal Cord Injury Investor Symposium - BioSpace

Jun 05, 2025

Jun 04, 2025

Deutsche Bank AG Has $87,000 Stock Position in Lineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX) - Defense World

Jun 04, 2025

May 27, 2025

Future of Personalized Treatment: Stem Cell Therapy Market - openPR.com

May 27, 2025

May 26, 2025

B. Riley Predicts Lineage Cell Therapeutics FY2029 Earnings - Defense World

May 26, 2025

May 21, 2025

Transcript : Lineage Cell Therapeutics, Inc. Presents at H.C. Wainwright 3rd Annual BioConnect Investor Conference 2025, May-20-2025 02 - marketscreener.com

May 21, 2025

May 20, 2025

Spinal cord injury Pipeline 2025: Groundbreaking Clinical - openPR.com

May 20, 2025

May 19, 2025

Cell Therapy Manufacturing Market Is Booming Worldwide | WuXi - openPR.com

May 19, 2025

May 17, 2025

Lineage Cell Therapeutics Q2 EPS Lowered by HC Wainwright - Defense World

May 17, 2025

May 16, 2025

Lineage Cell Therapeutics outlines manufacturing milestone and anticipates OpRegen 36-month data update while advancing OPC1 clinical plans - MSN

May 16, 2025

May 16, 2025

Comerica Bank Boosts Position in Lineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX) - Defense World

May 16, 2025

May 15, 2025

Lineage Cell Therapeutics’ Earnings Call Highlights Progress and Challenges - TipRanks

May 15, 2025

May 15, 2025

Barclays PLC Acquires 22,769 Shares of Lineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX) - Defense World

May 15, 2025

May 14, 2025

Lineage to Present at 3rd Annual H.C. Wainwright BioConnect Inve - GuruFocus

May 14, 2025

May 14, 2025

Lineage Cell Therapeutics Q1 2025 Earnings: EPS Beats Estimates at -$0.02, Revenue Misses at $1.5 Million - GuruFocus

May 14, 2025

May 14, 2025

Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q1 2025 Earnings Call Transcript - Insider Monkey

May 14, 2025

May 14, 2025

Lineage to Present at 3rd Annual H.C. Wainwright BioConnect Investor Conference at Nasdaq NYC - Business Wire

May 14, 2025

May 14, 2025

Wells Fargo & Company MN Increases Stake in Lineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX) - Defense World

May 14, 2025

May 14, 2025

Lineage Cell Therapeutics Inc (LCTX) Q1 2025 Earnings Call Highlights: Strategic Advances and ... - Yahoo Finance

May 14, 2025

May 14, 2025

Lineage Cell Therapeutics Inc (LCTX) Q1 2025 Earnings Call Highlights: Strategic Advances and Financial Resilience - GuruFocus

May 14, 2025

May 14, 2025

Lineage Cell Therapeutics Reports Q1 2025 Financials - TipRanks

May 14, 2025

May 13, 2025

Lineage Cell: Q1 Earnings Snapshot - Huron Daily Tribune

May 13, 2025

May 13, 2025

Lineage Cell Therapeutics earnings beat, revenue fell short of estimates By Investing.com - Investing.com Nigeria

May 13, 2025

May 13, 2025

Lineage Cell (LCTX) Reports Q1 Loss, Lags Revenue Estimates - Nasdaq

May 13, 2025

May 13, 2025

Lineage Cell Therapeutics Reports First Quarter 2025 Financial Results And Provides Business Update - marketscreener.com

May 13, 2025

May 13, 2025

Lineage Cell Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update - Business Wire

May 13, 2025

May 12, 2025

Examining the Future: Lineage Cell Therapeutics's Earnings Outlook - Nasdaq

May 12, 2025

May 12, 2025

RG6501 (OpRegen®) Phase 1/2a Clinical Study 36 Month Results to Be Featured at Clinical Trials at the Summit 2025 - Business Wire

May 12, 2025

May 07, 2025

Cell Therapy Manufacturing Market Projected To Witness Massive - openPR.com

May 07, 2025

May 01, 2025

Lineage Cell Therapeutics announces cGMP production success - Investing.com

May 01, 2025

May 01, 2025

Lineage Cell Therapeutics to Report First Quarter 2025 Financial Results and Provide Business Update on May 13, 2025 - BioSpace

May 01, 2025

May 01, 2025

Lineage Cell Therapeutics announces cGMP production success By Investing.com - Investing.com Nigeria

May 01, 2025

May 01, 2025

BlackRock, Inc.'s Strategic Acquisition of Lineage Cell Therapeu - GuruFocus

May 01, 2025

May 01, 2025

LCTX (Lineage Cell Therapeutics Inc) has impressive results - uspostnews.com

May 01, 2025

May 01, 2025

Lineage Cell Therapeutics (LCTX) to Release Earnings on Thursday - Defense World

May 01, 2025

May 01, 2025

JPMorgan Chase & Co. Raises Stock Holdings in Lineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX) - Defense World

May 01, 2025

Apr 30, 2025

Upward Trajectory: Lineage Cell Therapeutics Inc (LCTX) Posts a Gaine, Closing at 0.47 - DWinneX

Apr 30, 2025

Apr 30, 2025

Lineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX) Shares Bought by Renaissance Technologies LLC - Defense World

Apr 30, 2025

Apr 29, 2025

Lineage Cell Therapeutics Inc Inc. (LCTX) Price Performance: A Fundamental Analysis Perspective - investchronicle.com

Apr 29, 2025

Apr 25, 2025

Lineage Cell Therapeutics Inc [LCTX] Shares Rise 5.57 % on Thursday - knoxdaily.com

Apr 25, 2025

Apr 25, 2025

Stem Cell Therapy Market Growth, Trends, & Key Insights | Global - openPR.com

Apr 25, 2025